Table 4.
Distributions of Three Comorbidity Scores During the Baseline Year in Seniors in the Development Cohort (PA/PACE) and the Validation Cohort (NJ/PAAD)
Mean | SD | Percentage with Score = 0 | Median | IQR | Range | |
---|---|---|---|---|---|---|
Development cohort (PA/PACE) | ||||||
Romano/Charlson score | 3.00 | 2.81 | 21.0 | 2 | 4 | 0, 22 |
van Walraven/Elixhauser score | 5.96 | 7.36 | 23.8 | 4 | 10 | −13, 58 |
Combined comorbidity score | 1.76 | 2.59 | 22.7 | 1 | 3 | −2, 20 |
Validation cohort (NJ/PAAD) | ||||||
Romano/Charlson score | 2.37 | 2.54 | 29.9 | 2 | 4 | 0, 21 |
van Walraven/Elixhauser score | 4.76 | 6.63 | 33.1 | 3 | 7 | −12, 52 |
Combined comorbidity score | 1.23 | 2.30 | 27.1 | 1 | 2 | −2, 18 |
IQR, interquartile range; SD, standard deviation